IMGO NASDAQ
Imago BioSciences, Inc.
1W: +0.1%
1M: +0.4%
3M: +131.3%
1Y: +81.7%
$36.01
Last traded 2023-01-10 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$225M
+127.2% ▲
Total Liabilities
$10M
-94.0% ▼
Shareholders Equity
$215M
+412.1% ▲
Cash & Investments
$217M
+183.7% ▲
Total Debt
$0
+0.0% ▲
Net Debt
-$11M
+41.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| — Assets — | |||
| Cash | $5M | $19M | $11M |
| Short-Term Investments | $3M | $57M | $206M |
| Cash & ST Investments | $8M | $77M | $217M |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $788K | $1M | $4M |
| Total Current Assets | $8M | $78M | $221M |
| Property, Plant & Equip. | $0 | $8K | $2K |
| Goodwill & Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $20M | $0 |
| Other Non-Current Assets | $11K | $1M | $3M |
| Total Non-Current Assets | $11K | $21M | $3M |
| Total Assets | $9M | $99M | $225M |
| — Liabilities — | |||
| Accounts Payable | $1M | $1M | $3M |
| Short-Term Debt | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $1M | $4M | $7M |
| Total Current Liabilities | $3M | $5M | $10M |
| Long-Term Debt | $0 | $0 | $0 |
| Other Non-Current Liab. | $57M | $163M | $0 |
| Total Non-Current Liabilities | $57M | $163M | $3M |
| Total Liabilities | $60M | $168M | $10M |
| — Equity — | |||
| Common Stock | $0 | $0 | $3K |
| Retained Earnings | -$53M | -$70M | -$113M |
| Accumulated OCI | $1K | -$3K | -$43K |
| Total Stockholders Equity | -$51M | -$69M | $215M |
| Total Liabilities & Equity | $9M | $99M | $225M |
| — Key Metrics — | |||
| Total Debt | $0 | $0 | $0 |
| Net Debt | -$5M | -$19M | -$11M |
| Total Investments | $3M | $77M | $206M |